Influenza A H1N1 (A/Puerto Rico/8/1934) Neuraminidase / NA Protein (ECD, His Tag) sinobiological 40909-V08B
| Catalog No. | Size | Price (USD) |
| 40909-V08B-100 | 100 µg | $765.73 |
| Catalog No. | Size | Price (USD) |
| 40909-V08B-100 | 100 µg | $765.73 |
General Information
| Formulation | Supplied as sterile 20 mM Tris, 300 mM NaCl, 10% Glycerol, pH 8.0. Please contact us for any concerns or special requirements. Please refer to the specific buffer information in the hardcopy of datasheet or the lot-specific COA. |
| Endotoxin | < 1.0 EU per μg protein as determined by the LAL method. |
| Shipping | Liquid. It is shipped out with blue ice. |
| Stability & Storage | Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles. |
| Reconstitution | To find reconstitution info, click on 'COA' at the top of the page, enter the lot number and product size for the lot-specific COA. |
| Purity | ≥ 85 % as determined by SDS-PAGE. |
| Activity | Measured by its ability to cleave a fluorogenic substrate, 2'-(4-Methylumbelliferyl)-α-D-N-acetylneuraminic acid.The specific activity is >10,000 pmols/min/μg. |
| Protein Construction | A DNA sequence encoding the Influenza A virus (A/Puerto Rico/8/1934 (H1N1)) Neuraminidase / NA (BAK86309.1) (Ile30-Lys454) was expressed with a vasodilator-stimulated phosphoprotein tetramerization domain at the N-terminus and a polyhistidine tag at the C-terminus. |
| Accession# | BAK86309.1 |
| Expressed Host | Baculovirus-Insect Cells |
| Species | H1N1 |
| Predicted N Terminal | Asp |
| Molecule Mass | The recombinant NA subunit of the Influenza A virus (A/Puerto Rico/8/1934(H1N1)) consists 471 amino acids and predicts a molecular mass of 52.79 kDa. |
Image / Experimental Information
| Image 1 Alt Text | H1N1 Neuraminidase/NA Protein 36108 |
| Image 1 URL | Source image |
Background Information
| Description | Neuraminidases are enzymes that cleave sialic acid groups from glycoproteins. Influenza neuraminidase is a type of neuraminidase found on the surface of influenza viruses that enables the virus to be released from the host cell. Influenza neuraminidase is composed of four identical subunits arranged in a square. It is normally attached to the virus surface through a long protein stalk. The active sites are in a deep depression on the upper surface. They bind to polysaccharide chains and clip off the sugars at the end. The surface of neuraminidase is decorated with several polysaccharide chains that are similar to the polysaccharide chains that decorate our cell surface proteins. Neuraminidase (NA) and hemagglutinin (HA) are major membrane glycoproteins found on the surface of the influenza virus. Hemagglutinin binds to the sialic acid-containing receptors on the surface of host cells during initial infection and at the end of an infectious cycle. Neuraminidase, on the other hand, cleaves the HA-sialic acid bondage from the newly formed virions and the host cell receptors during budding. Neuraminidase thus is described as a receptor-destroying enzyme that facilitates virus release and efficient spread of the progeny virus from cell to cell. Influenza antibody and influenza antibodies are very important research tools for influenza diagnosis, influenza vaccine development, and anti-influenza virus therapy development. The monoclonal or polyclonal antibody can be raised with protein based antigen or peptide-based antigen. Antibodies raised with protein-based antigen could have better specificity and/or binding affinity than antibodies raised with peptide based antigen, but the cost associated with the recombinant protein antigen is usually higher. Anti-influenza virus hemagglutinin (HA) monoclonal antibody or polyclonal antibody can be used for ELISA assay, western blotting detection, Immunohistochemistry (IHC), flow cytometry, neutralization assay, hemagglutinin inhibition assay, and early diagnosis of influenza viral infection. Sino Biological has developed state-of-the-art monoclonal antibody development technology platforms: mouse monoclonal antibody and rabbit monoclonal antibody. Our rabbit monoclonal antibody platform is one of a kind and offers some unique advantages over mouse monoclonal antibodies, such as high affinity, low cross-reactivity with rabbit polyclonal antibodies. |
| References |
|
title: A plant gallotannin pentagalloyl d-glucose elicits antiviral activity against influenza A and B viruses through multi-targeting mechanisms.
authors: Sujeong Kim; Ju Won Kim; ...; Yo Han Jang
journal: Archives of Virology
date: 2026-03-24
pmid: 41874776
doi: 10.1007/s00705-026-06605-5
cited_by_count: 0
techniques: Recombinant; Virus
bioz_score: 94
title: A novel N -heterocycles substituted oseltamivir derivatives as potent inhibitors of influenza virus neuraminidase: discovery, synthesis and biological evaluation
authors: Jiwei Zhang; Chuanfeng Liu; ...; Xinyong Liu
journal: Journal of enzyme inhibition and medicinal chemistry
date: 2023-11-13
pmid: 37955306
doi: 10.1080/14756366.2023.2277135
pmcid: 10653643
cited_by_count: 2
techniques: Activity Assay; Chemiluminescence Immunoassay; In Vitro; Incubation; Inhibition; Virus
bioz_score: 94